• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Immunity . Co-immunization with hemagglutinin stem immunogens elicits cross-group neutralizing antibodies and broad protection against influenza A v

tetano

Editor, Senior Moderator
Immunity


. 2022 Nov 2;S1074-7613(22)00556-8.
doi: 10.1016/j.immuni.2022.10.015. Online ahead of print.
Co-immunization with hemagglutinin stem immunogens elicits cross-group neutralizing antibodies and broad protection against influenza A viruses


Syed M Moin[SUP] 1 [/SUP], Jeffrey C Boyington[SUP] 1 [/SUP], Seyhan Boyoglu-Barnum[SUP] 1 [/SUP], Rebecca A Gillespie[SUP] 1 [/SUP], Gabriele Cerutti[SUP] 2 [/SUP], Crystal Sao-Fong Cheung[SUP] 1 [/SUP], Alberto Cagigi[SUP] 1 [/SUP], John R Gallagher[SUP] 3 [/SUP], Joshua Brand[SUP] 1 [/SUP], Madhu Prabhakaran[SUP] 1 [/SUP], Yaroslav Tsybovsky[SUP] 4 [/SUP], Tyler Stephens[SUP] 4 [/SUP], Brian E Fisher[SUP] 1 [/SUP], Adrian Creanga[SUP] 1 [/SUP], Sila Ataca[SUP] 1 [/SUP], Reda Rawi[SUP] 1 [/SUP], Kizzmekia S Corbett[SUP] 5 [/SUP], Michelle C Crank[SUP] 1 [/SUP], Gunilla B Karlsson Hedestam[SUP] 6 [/SUP], Jason Gorman[SUP] 1 [/SUP], Adrian B McDermott[SUP] 1 [/SUP], Audray K Harris[SUP] 3 [/SUP], Tongqing Zhou[SUP] 1 [/SUP], Peter D Kwong[SUP] 1 [/SUP], Lawrence Shapiro[SUP] 7 [/SUP], John R Mascola[SUP] 1 [/SUP], Barney S Graham[SUP] 1 [/SUP], Masaru Kanekiyo[SUP] 8 [/SUP]



Affiliations

Abstract

Current influenza vaccines predominantly induce immunity to the hypervariable hemagglutinin (HA) head, requiring frequent vaccine reformulation. Conversely, the immunosubdominant yet conserved HA stem harbors a supersite that is targeted by broadly neutralizing antibodies (bnAbs), representing a prime target for universal vaccines. Here, we showed that the co-immunization of two HA stem immunogens derived from group 1 and 2 influenza A viruses elicits cross-group protective immunity and neutralizing antibody responses in mice, ferrets, and nonhuman primates (NHPs). Immunized mice were protected from multiple group 1 and 2 viruses, and all animal models showed broad serum-neutralizing activity. A bnAb isolated from an immunized NHP broadly neutralized and protected against diverse viruses, including H5N1 and H7N9. Genetic and structural analyses revealed strong homology between macaque and human bnAbs, illustrating common biophysical constraints for acquiring cross-group specificity. Vaccine elicitation of stem-directed cross-group-protective immunity represents a step toward the development of broadly protective influenza vaccines.

Keywords: HA stalk; HA stem; bnAb; cryo-EM; ferritin; influenza; nanoparticle; nonhuman primate; pandemic preparedness; vaccine.
 
Back
Top Bottom